Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination
The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We developed a dynamic transmission model of rotavirus to incorporate herd immunity into cost-effectiveness analysis. Our study indicates that a...
Saved in:
| Published in | Vaccine Vol. 27; no. 30; pp. 4025 - 4030 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Kidlington
Elsevier Ltd
19.06.2009
Elsevier Elsevier Limited |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We developed a dynamic transmission model of rotavirus to incorporate herd immunity into cost-effectiveness analysis. Our study indicates that a rotavirus vaccination program would prevent about 90% of rotavirus incidence, mortality, hospitalization and emergency department visits annually. We conclude that a universal rotavirus vaccine program in the US would cost $77.30 per case averted from the health care and give a net saving of $80.75 per case averted from the societal perspectives, respectively. The cost per QALY gained was found to be $104,610 when we considered child with one caregiver, making the rotavirus vaccination program a cost-effective intervention. |
|---|---|
| AbstractList | The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We developed a dynamic transmission model of rotavirus to incorporate herd immunity into cost-effectiveness analysis. Our study indicates that a rotavirus vaccination program would prevent about 90% of rotavirus incidence, mortality, hospitalization and emergency department visits annually. We conclude that a universal rotavirus vaccine program in the US would cost $77.30 per case averted from the health care and give a net saving of $80.75 per case averted from the societal perspectives, respectively. The cost per QALY gained was found to be $104,610 when we considered child with one caregiver, making the rotavirus vaccination program a cost-effective intervention. Abstract The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We developed a dynamic transmission model of rotavirus to incorporate herd immunity into cost-effectiveness analysis. Our study indicates that a rotavirus vaccination program would prevent about 90% of rotavirus incidence, mortality, hospitalization and emergency department visits annually. We conclude that a universal rotavirus vaccine program in the US would cost $77.30 per case averted from the health care and give a net saving of $80.75 per case averted from the societal perspectives, respectively. The cost per QALY gained was found to be $104,610 when we considered child with one caregiver, making the rotavirus vaccination program a cost-effective intervention. The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We developed a dynamic transmission model of rotavirus to incorporate herd immunity into cost-effectiveness analysis. Our study indicates that a rotavirus vaccination program would prevent about 90% of rotavirus incidence, mortality, hospitalization and emergency department visits annually. We conclude that a universal rotavirus vaccine program in the US would cost $77.30 per case averted from the health care and give a net saving of $80.75 per case averted from the societal perspectives, respectively. The cost per QALY gained was found to be $104,610 when we considered child with one caregiver, making the rotavirus vaccination program a cost-effective intervention.The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We developed a dynamic transmission model of rotavirus to incorporate herd immunity into cost-effectiveness analysis. Our study indicates that a rotavirus vaccination program would prevent about 90% of rotavirus incidence, mortality, hospitalization and emergency department visits annually. We conclude that a universal rotavirus vaccine program in the US would cost $77.30 per case averted from the health care and give a net saving of $80.75 per case averted from the societal perspectives, respectively. The cost per QALY gained was found to be $104,610 when we considered child with one caregiver, making the rotavirus vaccination program a cost-effective intervention. |
| Author | Galvani, Alison P. Shim, Eunha |
| Author_xml | – sequence: 1 givenname: Eunha surname: Shim fullname: Shim, Eunha email: eunha.shim@yale.edu – sequence: 2 givenname: Alison P. surname: Galvani fullname: Galvani, Alison P. email: alison.galvani@yale.edu |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21654091$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19389452$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkt2L1DAUxYOsuLOjf4JSENen1pu0TVMWXWTxY2FB8AN8C-ntLWbspGPSGZj_3tSOLgzo-pQ8_M7h3nPuGTtxgyPGHnPIOHD5YpXtDKJ1lAmAOoMigxzusQVXVZ6KkqsTtgAhi7Tg8PWUnYWwAoAy5_UDdsrrXNVFKRbs4_V6Y3BMhi4ZvXFhbUOwg0vavTNriyGJ__EbJTiEMaWuIxztjhyFMEn8MJqd9duQzMOYMWofsvud6QM9OrxL9uXtm89X79ObD--ur17fpCiFGlPZtRxNw2VLdQkVgpS1avPOCJJVY0xFsumwUkgGKy6VAFMW2BhVdFJwJfMlez77bvzwY0th1HF4pL43joZt0FUhoYqmZSTP_0nKKs9FEYNbsqdH4GrYehe30FxypVRe5SpSTw7UtllTqzfero3f69-pRuDZATABTd_FYNGGP5zgsiyg5pErZw79EIKn7tYK9NSyXulDy3pqWUOhY8tRd3GkQzv-yj52aPs71ZezmmI5O0teB7TkkFrrY726HeydDq-OHLC3zsZVv9Oewm1mOggN-tN0h9MZQh0vcE7w5d8N_mOAn2el78c |
| CODEN | VACCDE |
| CitedBy_id | crossref_primary_10_1016_j_jtbi_2010_07_027 crossref_primary_10_1186_1471_2458_10_253 crossref_primary_10_3389_fvets_2018_00084 crossref_primary_10_2165_11207210_000000000_00000 crossref_primary_10_1016_j_vaccine_2013_05_064 crossref_primary_10_1007_s40258_018_0436_0 crossref_primary_10_1016_j_amepre_2016_02_027 crossref_primary_10_1186_1471_2458_11_462 crossref_primary_10_1016_j_jval_2015_11_003 crossref_primary_10_1016_j_vaccine_2012_08_045 crossref_primary_10_1016_j_jval_2016_05_011 crossref_primary_10_1007_s11538_015_0107_3 crossref_primary_10_1080_21645515_2015_1131369 crossref_primary_10_1016_j_vaccine_2013_07_024 crossref_primary_10_1590_0102_311X00080515 crossref_primary_10_1016_j_acap_2011_09_003 crossref_primary_10_1016_j_anpedi_2011_09_022 crossref_primary_10_1017_S0950268816000881 crossref_primary_10_3111_13696998_2012_672942 crossref_primary_10_4161_hv_24253 crossref_primary_10_1016_j_vaccine_2017_10_024 crossref_primary_10_2165_11539960_000000000_00000 crossref_primary_10_1016_j_vaccine_2014_01_061 crossref_primary_10_1016_j_vaccine_2009_08_030 crossref_primary_10_1016_j_gfs_2014_09_003 crossref_primary_10_1586_erp_12_11 crossref_primary_10_1586_eri_10_1 crossref_primary_10_1007_s10198_023_01658_8 crossref_primary_10_1038_srep15468 crossref_primary_10_1093_jpids_pis058 crossref_primary_10_2165_00151234_200905840_00012 crossref_primary_10_1016_j_vaccine_2011_11_064 crossref_primary_10_1002_sim_6041 crossref_primary_10_1016_j_vaccine_2011_07_056 crossref_primary_10_4161_hv_29352 crossref_primary_10_1016_j_jval_2022_02_008 crossref_primary_10_1016_j_mbs_2023_108967 crossref_primary_10_1371_journal_pone_0183306 crossref_primary_10_1080_14760584_2021_1990043 crossref_primary_10_1016_j_vaccine_2012_09_025 crossref_primary_10_1542_peds_2010_0796 crossref_primary_10_1186_s12879_021_06629_z crossref_primary_10_1097_INF_0000000000002938 crossref_primary_10_1080_21645515_2015_1052196 crossref_primary_10_1177_0272989X10375579 crossref_primary_10_1007_s40273_023_01331_1 crossref_primary_10_1016_j_vaccine_2020_05_057 crossref_primary_10_1017_S0950268809991245 crossref_primary_10_1073_pnas_1110507108 crossref_primary_10_3201_eid2001_130019 crossref_primary_10_1098_rsif_2011_0062 crossref_primary_10_1016_j_vaccine_2017_04_051 crossref_primary_10_1177_0272989X14566013 crossref_primary_10_1016_j_vaccine_2023_06_064 crossref_primary_10_1186_1471_2334_11_174 |
| Cites_doi | 10.1016/j.vaccine.2007.10.009 10.1056/NEJMoa052434 10.1586/14737167.5.5.593 10.1086/431513 10.1542/peds.2006-2876 10.1128/CMR.00029-07 10.1590/S1020-49892007000300003 10.1177/000992289803701210 10.1016/j.vaccine.2007.02.070 10.1016/j.vaccine.2007.11.064 10.1590/S1020-49892007000300002 10.1001/jama.279.17.1371 |
| ContentType | Journal Article |
| Copyright | 2009 Elsevier Ltd Elsevier Ltd 2009 INIST-CNRS Copyright Elsevier Limited Jun 19, 2009 |
| Copyright_xml | – notice: 2009 Elsevier Ltd – notice: Elsevier Ltd – notice: 2009 INIST-CNRS – notice: Copyright Elsevier Limited Jun 19, 2009 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
| DOI | 10.1016/j.vaccine.2009.04.030 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) ProQuest Nursing & Allied Health Database (NC LIVE) Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Consumer Health Database (NC LIVE) ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE Research Library Prep MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-2518 |
| EndPage | 4030 |
| ExternalDocumentID | 3476902151 19389452 21654091 10_1016_j_vaccine_2009_04_030 S0264410X09005738 1_s2_0_S0264410X09005738 |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HEJ HLV HMCUK HMG HMK HMO HVGLF HX~ HZ~ IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAB SAE SCC SDF SDG SDP SES SEW SIN SNL SPCBC SSH SSI SSZ SVS T5K UKHRP UV1 WH7 WOW WUQ XPP Z5R ZGI ZXP ~G- 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGRNS AGWPP CITATION IQODW CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 |
| ID | FETCH-LOGICAL-c628t-6fd1cab16de9507c06698d3fa2e67baa7e6bfc78ceac716820a54cba84f621863 |
| IEDL.DBID | .~1 |
| ISSN | 0264-410X 1873-2518 |
| IngestDate | Tue Aug 05 09:56:11 EDT 2025 Thu Jul 10 22:17:19 EDT 2025 Sat Aug 23 12:46:17 EDT 2025 Mon Jul 21 06:02:38 EDT 2025 Mon Jul 21 09:14:23 EDT 2025 Tue Jul 01 03:37:40 EDT 2025 Thu Apr 24 23:09:14 EDT 2025 Fri Feb 23 02:28:41 EST 2024 Sun Feb 23 10:19:56 EST 2025 Tue Aug 26 17:02:18 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 30 |
| Keywords | Rotavirus Cost-effectiveness Vaccination Virus Transmission Reoviridae Cost efficiency analysis |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c628t-6fd1cab16de9507c06698d3fa2e67baa7e6bfc78ceac716820a54cba84f621863 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 19389452 |
| PQID | 1618883738 |
| PQPubID | 105530 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_746076695 proquest_miscellaneous_67332487 proquest_journals_1618883738 pubmed_primary_19389452 pascalfrancis_primary_21654091 crossref_primary_10_1016_j_vaccine_2009_04_030 crossref_citationtrail_10_1016_j_vaccine_2009_04_030 elsevier_sciencedirect_doi_10_1016_j_vaccine_2009_04_030 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X09005738 elsevier_clinicalkey_doi_10_1016_j_vaccine_2009_04_030 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2009-06-19 |
| PublicationDateYYYYMMDD | 2009-06-19 |
| PublicationDate_xml | – month: 06 year: 2009 text: 2009-06-19 day: 19 |
| PublicationDecade | 2000 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: Netherlands |
| PublicationTitle | Vaccine |
| PublicationTitleAlternate | Vaccine |
| PublicationYear | 2009 |
| Publisher | Elsevier Ltd Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Elsevier Limited |
| References | (bib17) 2007; 119 Haddix, Teutsch, Shaffer, Duet (bib19) 1996 Steele (bib12) 1998; 37 Rheingans, Constenla, Antil, Innis, Breuer (bib5) 2007; 21 The Consumer Price Indexes (CPI): all urban consumers 2007 [cited November 26, 2007]; Available from Tucker, Haddix, Bresee, Holman, Parashar, Glass (bib9) 1998; 279 Lorgelly, Joshi, Iturriza Gomara, Gray, Mugford (bib10) 2007; 5 Ruiz-Palacios, Perez-Schael, Velazquez, Abate, Breuer, Clemens (bib14) 2006; 354 Dennehy (bib16) 2008; 21 Widdowson, Meltzer, Zhang, Bresee, Parashar, Glass (bib4) 2007; 119 Rheingans, Constenla, Antil, Innis, Breuer (bib22) 2007; 21 Senecal, Brisson, Lebel, Yaremko, Wong, Gallant (bib15) 2006 Jit, Edmunds (bib11) 2007; 25 . Podewils, Antil, Hummelman, Bresee, Parashar, Rheingans (bib2) 2005; 192 Newall, Beutels, Macartney, Wood, Macintyre (bib6) 2007; 25 WHO. Report of the Commission on Macroeconomics and Health. Geneva; 2002. Smith, Haddix, Teutsch, Glass (bib8) 1995; 96 Walker, Rheingans (bib3) 2005; 5 Anderson, May (bib13) 1991 CIA. The World Factbook. Rank Order – GDP – per capita (PPP). December 13, 2007 ed: Central Intelligence Agency; 2007. Melliez, Levybruhl, Boelle, Dervaux, Baron, Yazdanpanah (bib7) 2008; 26 Kapikian, Chanock (bib1) 1990 Rheingans (10.1016/j.vaccine.2009.04.030_bib5) 2007; 21 10.1016/j.vaccine.2009.04.030_bib21 Kapikian (10.1016/j.vaccine.2009.04.030_bib1) 1990 Tucker (10.1016/j.vaccine.2009.04.030_bib9) 1998; 279 10.1016/j.vaccine.2009.04.030_bib20 Smith (10.1016/j.vaccine.2009.04.030_bib8) 1995; 96 Anderson (10.1016/j.vaccine.2009.04.030_bib13) 1991 Walker (10.1016/j.vaccine.2009.04.030_bib3) 2005; 5 Widdowson (10.1016/j.vaccine.2009.04.030_bib4) 2007; 119 (10.1016/j.vaccine.2009.04.030_bib17) 2007; 119 Rheingans (10.1016/j.vaccine.2009.04.030_bib22) 2007; 21 Steele (10.1016/j.vaccine.2009.04.030_bib12) 1998; 37 Podewils (10.1016/j.vaccine.2009.04.030_bib2) 2005; 192 Ruiz-Palacios (10.1016/j.vaccine.2009.04.030_bib14) 2006; 354 Dennehy (10.1016/j.vaccine.2009.04.030_bib16) 2008; 21 Newall (10.1016/j.vaccine.2009.04.030_bib6) 2007; 25 Jit (10.1016/j.vaccine.2009.04.030_bib11) 2007; 25 Haddix (10.1016/j.vaccine.2009.04.030_bib19) 1996 Melliez (10.1016/j.vaccine.2009.04.030_bib7) 2008; 26 Senecal (10.1016/j.vaccine.2009.04.030_bib15) 2006 10.1016/j.vaccine.2009.04.030_bib18 Lorgelly (10.1016/j.vaccine.2009.04.030_bib10) 2007; 5 |
| References_xml | – volume: 25 start-page: 8851 year: 2007 end-page: 8860 ident: bib6 article-title: The cost-effectiveness of rotavirus vaccination in Australia publication-title: Vaccine – volume: 5 start-page: 1 year: 2007 end-page: 12 ident: bib10 article-title: Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom publication-title: Epidemiol Infect – volume: 354 start-page: 11 year: 2006 end-page: 22 ident: bib14 article-title: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis publication-title: N Engl J Med – volume: 119 start-page: 207 year: 2007 end-page: 208 ident: bib17 article-title: Recommended immunization schedules for children and adolescents—United States publication-title: Pediatrics – volume: 21 start-page: 192 year: 2007 end-page: 204 ident: bib22 article-title: Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries publication-title: Rev Panam Salud Publica – volume: 21 start-page: 205 year: 2007 end-page: 216 ident: bib5 article-title: Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries publication-title: Rev Panam Salud Publica – volume: 21 start-page: 198 year: 2008 end-page: 208 ident: bib16 article-title: Rotavirus vaccines: an overview publication-title: Clin Microbiol Rev – reference: The Consumer Price Indexes (CPI): all urban consumers 2007 [cited November 26, 2007]; Available from: – start-page: 1353 year: 1990 end-page: 1404 ident: bib1 article-title: Rotaviruses publication-title: Virology – volume: 119 start-page: 684 year: 2007 end-page: 697 ident: bib4 article-title: Cost-effectiveness and potential impact of rotavirus vaccination in the United States publication-title: Pediatrics – volume: 96 start-page: 609 year: 1995 end-page: 615 ident: bib8 article-title: Cost-effectiveness analysis of a rotavirus immunization program for the United States publication-title: Pediatrics – year: 1996 ident: bib19 article-title: Prevention effectiveness – volume: 26 start-page: 706 year: 2008 end-page: 715 ident: bib7 article-title: Cost and cost-effectiveness of childhood vaccination against rotavirus in France publication-title: Vaccine – volume: 25 start-page: 3971 year: 2007 end-page: 3979 ident: bib11 article-title: Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination publication-title: Vaccine – volume: 5 start-page: 593 year: 2005 end-page: 601 ident: bib3 article-title: The cost-effectiveness of rotavirus vaccines publication-title: Expert Rev Pharmacoecon Outcomes Res – reference: WHO. Report of the Commission on Macroeconomics and Health. Geneva; 2002. – volume: 192 start-page: S133 year: 2005 end-page: S145 ident: bib2 article-title: Projected cost-effectiveness of rotavirus vaccination for children in Asia publication-title: J Infect Dis – volume: 37 start-page: 758 year: 1998 end-page: 759 ident: bib12 article-title: Cost-effectiveness analysis of a rotavirus immunization program for the United States publication-title: Clin Pediatr (Phila) – reference: CIA. The World Factbook. Rank Order – GDP – per capita (PPP). December 13, 2007 ed: Central Intelligence Agency; 2007. – year: 1991 ident: bib13 article-title: Infectious diseases of humans: dynamics and control – year: 2006 ident: bib15 article-title: Burden of rotavirus associated gastroenteritis in Canadian families: a prospective community based study publication-title: Presented at the 244h Annual Meeting of the European Society for Paediatric Infectious Diseases – reference: . – volume: 279 start-page: 1371 year: 1998 end-page: 1376 ident: bib9 article-title: Cost-effectiveness analysis of a rotavirus immunization program for the United States publication-title: JAMA – volume: 25 start-page: 8851 issue: December (52) year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib6 article-title: The cost-effectiveness of rotavirus vaccination in Australia publication-title: Vaccine doi: 10.1016/j.vaccine.2007.10.009 – volume: 354 start-page: 11 issue: January (1) year: 2006 ident: 10.1016/j.vaccine.2009.04.030_bib14 article-title: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis publication-title: N Engl J Med doi: 10.1056/NEJMoa052434 – volume: 5 start-page: 593 issue: 5 year: 2005 ident: 10.1016/j.vaccine.2009.04.030_bib3 article-title: The cost-effectiveness of rotavirus vaccines publication-title: Expert Rev Pharmacoecon Outcomes Res doi: 10.1586/14737167.5.5.593 – volume: 192 start-page: S133 issue: September (Suppl 1) year: 2005 ident: 10.1016/j.vaccine.2009.04.030_bib2 article-title: Projected cost-effectiveness of rotavirus vaccination for children in Asia publication-title: J Infect Dis doi: 10.1086/431513 – ident: 10.1016/j.vaccine.2009.04.030_bib18 – year: 1991 ident: 10.1016/j.vaccine.2009.04.030_bib13 – volume: 119 start-page: 207 issue: January (1) year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib17 article-title: Recommended immunization schedules for children and adolescents—United States publication-title: Pediatrics – year: 1996 ident: 10.1016/j.vaccine.2009.04.030_bib19 – volume: 119 start-page: 684 issue: April (4) year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib4 article-title: Cost-effectiveness and potential impact of rotavirus vaccination in the United States publication-title: Pediatrics doi: 10.1542/peds.2006-2876 – year: 2006 ident: 10.1016/j.vaccine.2009.04.030_bib15 article-title: Burden of rotavirus associated gastroenteritis in Canadian families: a prospective community based study – volume: 21 start-page: 198 issue: January (1) year: 2008 ident: 10.1016/j.vaccine.2009.04.030_bib16 article-title: Rotavirus vaccines: an overview publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00029-07 – volume: 21 start-page: 205 issue: April (4) year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib5 article-title: Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries publication-title: Rev Panam Salud Publica doi: 10.1590/S1020-49892007000300003 – start-page: 1353 year: 1990 ident: 10.1016/j.vaccine.2009.04.030_bib1 article-title: Rotaviruses – volume: 5 start-page: 1 issue: March year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib10 article-title: Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom publication-title: Epidemiol Infect – volume: 37 start-page: 758 issue: December (12) year: 1998 ident: 10.1016/j.vaccine.2009.04.030_bib12 article-title: Cost-effectiveness analysis of a rotavirus immunization program for the United States publication-title: Clin Pediatr (Phila) doi: 10.1177/000992289803701210 – volume: 25 start-page: 3971 issue: May (20) year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib11 article-title: Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination publication-title: Vaccine doi: 10.1016/j.vaccine.2007.02.070 – ident: 10.1016/j.vaccine.2009.04.030_bib20 – volume: 26 start-page: 706 issue: January (5) year: 2008 ident: 10.1016/j.vaccine.2009.04.030_bib7 article-title: Cost and cost-effectiveness of childhood vaccination against rotavirus in France publication-title: Vaccine doi: 10.1016/j.vaccine.2007.11.064 – ident: 10.1016/j.vaccine.2009.04.030_bib21 – volume: 21 start-page: 192 issue: April (4) year: 2007 ident: 10.1016/j.vaccine.2009.04.030_bib22 article-title: Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries publication-title: Rev Panam Salud Publica doi: 10.1590/S1020-49892007000300002 – volume: 96 start-page: 609 issue: October (4 Pt 1) year: 1995 ident: 10.1016/j.vaccine.2009.04.030_bib8 article-title: Cost-effectiveness analysis of a rotavirus immunization program for the United States publication-title: Pediatrics – volume: 279 start-page: 1371 issue: May (17) year: 1998 ident: 10.1016/j.vaccine.2009.04.030_bib9 article-title: Cost-effectiveness analysis of a rotavirus immunization program for the United States publication-title: JAMA doi: 10.1001/jama.279.17.1371 |
| SSID | ssj0005319 |
| Score | 2.1973283 |
| Snippet | The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine, RotaTeq. We... Abstract The objective of this study is to estimate the cost-effectiveness of mass vaccination of US infants with the recently available rotavirus vaccine,... |
| SourceID | proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 4025 |
| SubjectTerms | Allergy and Immunology Applied microbiology Biological and medical sciences Child, Preschool Children & youth Cost-Benefit Analysis Cost-effectiveness Diarrhea Emergency medical services Fundamental and applied biological sciences. Psychology Herd immunity Hospitalization Hospitals Humans Incidence Infant Microbiology Miscellaneous Rotavirus Rotavirus Infections - economics Rotavirus Infections - mortality Rotavirus Infections - prevention & control Rotavirus Infections - transmission Rotavirus Vaccines - administration & dosage Rotavirus Vaccines - economics Rotavirus Vaccines - immunology United States Vaccination Vaccination - economics Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Attenuated - administration & dosage Vaccines, Attenuated - economics Vaccines, Attenuated - immunology Virology |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ba9RAFB60oggiul4arXUepE_NNpfJXJ5ExFKFStFW9m2YTCbQIpvtTrbQf--ZSxKE1voWSA5J5pw5882cy4fQB14YXlFBYIrXZUoYcS1v6yoVtRGkLXTFPZ3P8Xd6dEa-LapFPHCzMa1y8IneUTeddmfkB66xO-euD8_H1WXqWKNcdDVSaNxHD1zrMmfVbMGmFI_SE3vANoOkJM8WUwXPwcX8SmkXuo4tK8ncJ0LfvDY9WSkLI9YGqovbsahfkw6foacRTOJPQfvP0T2znKGHgV7yeoYeHcfA-QztnYQW1df7-HSquLL7eA-fTM2rQWb2y-XH-CJdPIi_QD---mJK3LW4d4sbGIc7ZcNN4LO3GK4BSWLd2T4NKSLRizqRdderq_P1xuIwGt4YXqKzwy-nn4_SyMaQalrwPqVtk2tV57QxAkCkBqwieFO2qjCU1UoxQ-tWM67BlcMmDJCFqoiuFSctdcRX5Su0teyWZhthJWATWTQ5iBZEGRfcVaQqasbqEvBllSAy6EHq2KrcMWb8lkNO2oWM6nM0mkJmRIL6EjQfxVahV8ddAnRQshwKUcF1SlhN7hJkNwkaGx2Albm0hczkz8wDzmyRCd96kieIj5IR4wTs8j8v3f3LDsd_LFxFGuC-BO0MhimnDxnnTYLej7fBTFxgSC1Nt7Eutw9wNWcJwrc8AXM4Y6BwUM3rYPHTCAvAvKC9N_9--1v0OATiaJqLHbTVrzfmHeC5vt71k_YPnwtJJg priority: 102 providerName: ProQuest |
| Title | Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X09005738 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X09005738 https://dx.doi.org/10.1016/j.vaccine.2009.04.030 https://www.ncbi.nlm.nih.gov/pubmed/19389452 https://www.proquest.com/docview/1618883738 https://www.proquest.com/docview/67332487 https://www.proquest.com/docview/746076695 |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBelY2MwxpZ9ees6PYw-1Yk_ZEl-7EJLutEQunbkTciyDCkjDrFT6Mv-9p0-HK-spWMvtrF12Nad7n72fSH0mSeaZzQnsMSLNCSMmJK3RRbmhc5JlaiM23Y-Z1M6uSRf59l8B427XBgTVul1v9PpVlv7MyM_m6PVYjH6HllbHs2j3Fb1Mwm_hDAj5cNff4R5pLa5hxkcmtF9Fs_oangtlXFf-7KVZGiDoe-2T89WsoFZq1y7i_vxqLVLJy_Qcw8o8ZF75pdoRy8H6LFrMXkzQE_OvPN8gA5mrkz1zSG-6LOumkN8gGd9AWugGfwwMTI2URd35K_Q-alNqMR1hVtj4EBAzJ82XLqe9g2GY0CTWNVNG7owEa9JDcm6buX1Yr1psJsNKxCv0eXJ8cV4EvqODKGiCW9DWpWxkkVMS50DkFSAV3JeppVMNGWFlEzTolKMK1Dn8CEG6EJmRBWSk4qa5lfpG7S7rJf6HcIyhw_JpIyBNCFSGwevJFlSMFakgDGzAJGOD0L5cuWma8ZP0cWlXQnPPtNKMxcREcC-AA23ZCtXr-MhAtoxWXTJqKA-BViUhwjZXYS68UqgEbFoEhGJvwQ1QHxLeUvW_-Wm-7fkcPuOiclKA-wXoL1OMEX_IDTmnKf21p-2l0FMjHNILnW9aUx8H2BrzgKE7xkB6zhiwHBgzVsn8f0M54B7gXvv___NPqCnzlFHwzjfQ7vteqM_At5ri327oGHL5gy2fAzHj45Ov02msP9yPJ2d_waCyVgU |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIh4SQhBehtLuAXqqU3u9ttcHhFChSmhTVZBWuS3r9VqigjjETlH-FL-R2fUjILWUS2-RnPHrm5351vMCeMWp5mGUMFziaeCymJmWt2noJqlOWE5VyO04n9FRNDhhHyfhZA1-tbUwJq2ytYnWUGeFMt_Id01jd85NH563sx-umRploqvtCI1aLQ708idu2co3w_eI72tK9z-M9wZuM1XAVRHllRvlma9k6keZTpAMKfS5Cc-CXFIdxamUsY7SXMVcoUnCzQR6SBkylUrO8sgMcArwvDfgJgtwaZrK9L0_UkoCO0gEtzXMZb43WVUM7Z71z6UyofKmRSbr28Tri33hvZksEaG8Hq1xOfe1PnD_AdxvyCt5V2vbQ1jT0x7cqsdZLntwe9QE6nuwfVy3xF7ukPGqwqvcIdvkeNUsG2V6pyYfxxYFk1b8EXwa2uJNUuSkMs4UldF81SPZciq_43kI_kbmSlRRVm6dktJYbSMyLyp5_nW-KEn9NqzyPYaTa8HpCaxPi6l-BkQmuGmlmY-ilEltgsmShTSN4zRAPhs6wFochGpao5sJHd9EmwN3Jhr4zNjORHhMIHwO9DuxWd0b5CqBqAVZtIWvaKoFeq-rBOOLBHXZGJxS-KKkwhOfPUtwvYmX2FaX3AHeSTacquZK_3PRzb_0sHtGairgkGc6sNEqpljdSLdOHdjqDqOamECUnOpiUZpcQuTxPHaAXPIPtBlejIAjNE9rjV-94QQ5NqL3_N9X34I7g_HoUBwOjw5ewN06CBi5frIB69V8oV8il6zSTbuACXy5bovxGzvahy0 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIiokhCC8DKXdA_RUJ_Z67V0fEEItUUNpFUGLctuu7bVEBXaInaL8NX4ds2s7AamlXHqL5Ixf3-zMt54XwCtBtQijmOESTwKXcWZa3iahGyc6ZjlNQ2HH-RwdRwen7MMknKzBr64WxqRVdjbRGuqsTM038oFp7C6E6cMzyNu0iPH-8O30h2smSJlIazdOo1GRQ734idu36s1oH7F-Tenw_cnegdtOGHDTiIrajfLMT1XiR5mOkRil6H9jkQW5ojriiVJcR0mecpGiecKNBXpLFbI0UYLlkRnmFOB5b8FtHnBh1pjY-yO9JLBDRXCLw1zme5NV9dDgvH-hUhM2b9tlsr5Nwr7cL96bqgrRypsxG1fzYOsPhw_gfktkybtG8x7Cmi56cKcZbbnowcZRG7Tvwc64aY-92CUnq2qvapfskPGqcTbK9L6Y3BxbIEw68UfwaWQLOUmZk9o4VlRM84WPZItCfcfzEPyNLJakZVW7TXpKa8GNyKys1cXX2bwizduwivgYTm8EpyewXpSFfgZExbiBpZmPopQpbQLLioU04TwJkNuGDrAOB5m2bdLNtI5vssuHO5ctfGaEZyw9JhE-B_pLsWnTJ-Q6gagDWXZFsGi2JXqy6wT5ZYK6ao1PJX1ZUenJz54lu97Ei23bS-GAWEq2_KrhTf9z0a2_9HD5jNRUwyHndGCzU0y5upHlmnVge3kY1cQEpVShy3ll8gqR0wvuALniH2g_PI6AIzRPG41fveEY-Tai9_zfV9-GDbQV8uPo-PAF3G3igZHrx5uwXs_m-iXSyjrZsuuXwNlNG4zfh4OLYw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+transmission+dynamics+on+the+cost-effectiveness+of+rotavirus+vaccination&rft.jtitle=Vaccine&rft.au=Shim%2C+Eunha&rft.au=Galvani%2C+Alison+P.&rft.date=2009-06-19&rft.issn=0264-410X&rft.volume=27&rft.issue=30&rft.spage=4025&rft.epage=4030&rft_id=info:doi/10.1016%2Fj.vaccine.2009.04.030&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_vaccine_2009_04_030 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X09X00277%2Fcov150h.gif |